e-Therapeutics (ETX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.75p
   
  • Change Today:
    -0.20p
  • 52 Week High: 23.10
  • 52 Week Low: 8.13
  • Currency: UK Pounds
  • Shares Issued: 584.34m
  • Volume: 61,764
  • Market Cap: £56.97m
Select chart: 1 week | 1 month
 

Current

1 week

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Jan-24 0.50 n/a (1.54)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (£m)
 
Earnings
 
Dividend
 
Recommendations
Strong Buy 0 0 0 0 0 0
Buy 0 0 0 0 0 0
Neutral 0 0 0 0 0 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 0 0 0 0 0 0
 
Average Rec n/a n/a n/a n/a n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

e-Therapeutics Market Data

Currency UK Pounds
Share Price 9.75p
Change Today -0.20p
% Change -2.01 %
52 Week High 23.10
52 Week Low 8.13
Volume 61,764
Shares Issued 584.34m
Market Cap £56.97m

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.56% below the market average23.56% below the market average23.56% below the market average23.56% below the market average23.56% below the market average
39.62% above the sector average39.62% above the sector average39.62% above the sector average39.62% above the sector average39.62% above the sector average
Price Trend
59.08% below the market average59.08% below the market average59.08% below the market average59.08% below the market average59.08% below the market average
29.82% above the sector average29.82% above the sector average29.82% above the sector average29.82% above the sector average29.82% above the sector average
Income Not Available
Growth
15.32% below the market average15.32% below the market average15.32% below the market average15.32% below the market average15.32% below the market average
24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average

e-Therapeutics Dividends

No dividends found

Trades for 19-Apr-2024

Time Volume / Share Price
10:01 52,794 @ 9.66p
08:43 8,970 @ 9.75p

e-Therapeutics Key Personnel

Chair Trevor Mervyn Jones
CEO Ali Mortazavi

Top of Page